Related Experiment Video
Updated: May 5, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Beyond contracts: principles for Pharma-CRO collaboration from the European Bioanalysis Forum
Philip Timmerman1, Matthew Barfield2, Lee Goodwin3
1European Bioanalysis Forum, Brussels, Belgium.
None:
Collaboration between pharmaceutical companies and contract research organizations is central to drug development, yet projects often stumble on well-known weaknesses: communication that does not adapt to the phase of work, expectations that remain unclear, partnerships reduced to transactions, and functions working in silos. Within the European Bioanalysis Forum, two dedicated teams examined these issues in depth, focusing on communication and on building sustainable partnerships. Their reflections were calibrated through dialogue with the wider community during a Focus Workshop, and sharpened by the perspective of the Forum's leadership. This paper brings forward a number of principles that, in the view of the teams and delegates, are essential to more reliable collaboration. They are not an exhaustive list, but a structured starting point for reflection. Reliable collaboration enables science to move forward efficiently and, ultimately, to benefit the patient.
Related Concept Videos
Biopharmaceutics and Pharmacokinetics: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioequivalence studies: Biowaivers
Drug Products: Biologics, Biosimilars and Interchangeables
Biopharmaceutical Factors Influencing Drug Product Design: Overview

